Nakashima Hiroshi, Emi Kazuyuki, Sato Tatsuhiko, Iwahashi-Shima Chiharu, Bando Hajime, Ikeda Toshihide
Osaka Rosai Hospital Clinical Research Center for Optical Sensory Organ Disability, Sakai, Japan.
Nippon Ganka Gakkai Zasshi. 2012 Jun;116(6):560-7.
The effectiveness of laser photocoagulation and/or cryopexy to the abnormal retinal vessels for the treatment of eyes with Coats disease is reported. However, in Coats cases with serous detachment laser photocoagulation and/or cryopexy is sometimes not enough to coagulate and consecutively scar the abnormal vessels, leading to persistent subretinal fluid and multiple courses of treatment. Therefore, we investigated the long-term prognosis of Stage 3A Coats cases with macular detachment which underwent vitrectomy.
Five eyes of 5 cases (all men) with Stage 3A Coats disease, which underwent primary vitrectomy between 1999 and 2009, were investigated retrospectively. The average age at vitrectomy was 13.8 years (range; 6-21 years) and the average preoperative visual acuity in decimal equivalent was 0.1 (range; 0.04-0.5). The average follow-up period after vitrectomy was 83 months (range; 13-137 months). In the vitrectomy, posterior vitreous detachment either occurred or was confirmed. An intentional retinal hole was made and the subretinal fluid was drained through the hole. The abnormal vessels were coagulated by endo-diathermy and/or laser photocoagulation. The vitreous fluid was replaced with long-lasting gas or air. The visual acuity and the findings from the ocular fundus both before and after the vitrectomy were investigated.
The average best-corrected visual acuities in decimal equivalent before, 3 and 12 months after the vitrectomy, and at the final visit were 0.1, 0.2, 0.2, 0.4, respectively. There was a statistically significant (p = 0.007) difference between the 4 time points, and the visual acuities at 12 months after vitrectomy and the final visit were significantly (p < 0.05) better than before the vitrectomy. The macular part of the retina in all 5 cases was attached once the gas in the vitreous cavity had disappeared. The foveal exudation which was observed before the vitrectomy in all 5 cases was completely absorbed after the vitrectomy. The average period from the vitrectomy to the complete absorption of the exudation was 20 months. Subfoveal fibrosis was observed in 4 of the 5 eyes and chorioretinal atrophy occurred in 3.
Vitrectomy for eyes with Stage 3A Coats disease may be effective for visual prognosis compared to conventional therapy, i.e., laser photocoagulation and cryopexy, by enabling retinal attachment in the early postoperative period and by causing the foveal exudation to disappear.
报告激光光凝和/或冷冻疗法对Coats病患者异常视网膜血管的治疗效果。然而,在伴有浆液性脱离的Coats病病例中,激光光凝和/或冷冻疗法有时不足以凝固并连续瘢痕化异常血管,导致持续性视网膜下液和多次治疗。因此,我们研究了接受玻璃体切除术的3A期Coats病黄斑脱离患者的长期预后。
回顾性研究1999年至2009年间接受初次玻璃体切除术的5例(均为男性)3A期Coats病患者的5只眼。玻璃体切除术时的平均年龄为13.8岁(范围6 - 21岁),术前平均小数视力为0.1(范围0.04 - 0.5)。玻璃体切除术后的平均随访期为83个月(范围13 - 137个月)。在玻璃体切除术中,发生或确认了玻璃体后脱离。制造一个故意的视网膜裂孔,并通过该裂孔引流视网膜下液。通过眼内透热疗法和/或激光光凝凝固异常血管。用长效气体或空气替代玻璃体。研究玻璃体切除术前后的视力和眼底检查结果。
玻璃体切除术术前、术后3个月、12个月及末次随访时的平均最佳矫正小数视力分别为0.1、0.2、0.2、0.4。这4个时间点之间存在统计学显著差异(p = 0.007),玻璃体切除术后12个月及末次随访时的视力明显(p < 0.05)优于玻璃体切除术之前。一旦玻璃体腔内的气体消失,所有5例患者的视网膜黄斑部分均附着。所有5例患者玻璃体切除术之前观察到的黄斑部渗出在玻璃体切除术后完全吸收。渗出完全吸收的平均时间为玻璃体切除术后20个月。5只眼中有4只观察到黄斑下纤维化,3只发生脉络膜视网膜萎缩。
与传统治疗方法(即激光光凝和冷冻疗法)相比,3A期Coats病患者的玻璃体切除术可能通过使术后早期视网膜附着并使黄斑部渗出消失而对视力预后有效。